Elise C Kohn Selected Research

Elise C Kohn Research Topics

Disease

68	Neoplasms (Cancer) 11/2021 - 01/2002
56	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
11	Ovarian Epithelial Carcinoma 02/2016 - 01/2002
10	Carcinoma (Carcinomatosis) 11/2020 - 09/2003
5	Neutropenia 04/2019 - 10/2009
5	Hypertension (High Blood Pressure) 12/2018 - 02/2009
4	Fatigue 07/2017 - 07/2007
4	Leukemia 03/2012 - 11/2006
4	Prostatic Neoplasms (Prostate Cancer) 07/2010 - 10/2002
4	Colonic Neoplasms (Colon Cancer) 07/2008 - 03/2005
3	Disease Progression 01/2020 - 05/2009
3	Thrombocytopenia (Thrombopenia) 04/2019 - 03/2017
3	Carcinogenesis 01/2017 - 09/2003
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 11/2007
3	Neoplasm Metastasis (Metastasis) 08/2009 - 05/2004
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2018
2	Adenocarcinoma 01/2021 - 11/2007
2	Triple Negative Breast Neoplasms 01/2019 - 10/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2016
2	Melanoma (Melanoma, Malignant) 11/2014 - 10/2003
2	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 03/2005
2	Breast Neoplasms (Breast Cancer) 08/2009 - 09/2006
2	Xeroderma Pigmentosum (Kaposi's Disease) 01/2008 - 06/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2006 - 09/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2005 - 09/2004
1	Genomic Instability 10/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Peritoneal Diseases 01/2020
1	Sepsis (Septicemia) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2019
1	Infections 04/2019

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2002
25	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2002
16	Pharmaceutical PreparationsIBA 01/2020 - 02/2005
14	olaparibIBA 01/2022 - 06/2014
11	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 01/2014
10	carboxyamido-triazole (carboxyamidotriazole)IBA 10/2009 - 03/2003
9	PlatinumIBA 01/2022 - 10/2014
7	cediranib (AZD2171)IBA 01/2022 - 10/2014
7	Bevacizumab (Avastin)FDA Link 10/2020 - 08/2008
6	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 08/2008
6	Phosphotransferases (Kinase)IBA 10/2020 - 04/2007
6	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 09/2003
6	Carboplatin (JM8)FDA LinkGeneric 04/2019 - 07/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 11/2007
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2003
5	ProgranulinsIBA 01/2011 - 01/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2003
4	Asparaginase (Elspar)FDA Link 05/2013 - 11/2006
4	Secretory Leukocyte Peptidase InhibitorIBA 09/2011 - 03/2008
4	GranulinsIBA 10/2005 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2008
3	Biological ProductsIBA 01/2019 - 02/2006
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016 - 01/2014
3	ProteomeIBA 11/2011 - 09/2003
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 07/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2010 - 11/2007
3	Cisplatin (Platino)FDA LinkGeneric 03/2010 - 11/2007
3	RNA (Ribonucleic Acid)IBA 10/2008 - 01/2002
2	Gemcitabine FDA Link 01/2021 - 01/2020
2	berzosertibIBA 01/2021 - 01/2020
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2019 - 01/2019
2	durvalumabIBA 01/2019 - 07/2017
2	Drug CombinationsIBA 01/2019 - 01/2014
2	Caspase 3 (Caspase-3)IBA 02/2016 - 10/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 01/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2015 - 10/2003
2	EnzymesIBA 02/2013 - 11/2006
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2011 - 03/2009
2	Transcription Factors (Transcription Factor)IBA 07/2010 - 05/2010
2	NF-kappa B (NF-kB)IBA 07/2010 - 05/2010
2	CalciumIBA 10/2009 - 03/2005
2	Proline (L-Proline)FDA Link 08/2009 - 09/2006
2	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 03/2008
2	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 10/2008 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 07/2007 - 04/2007
2	lysophosphatidic acidIBA 10/2005 - 01/2002
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021
1	AntigensIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 09/2019
1	CyclinsIBA 09/2019
1	Investigational DrugsIBA 09/2019
1	Angiogenesis InhibitorsIBA 09/2019
1	human ERBB2 proteinIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	RadiopharmaceuticalsIBA 01/2019
1	DeoxyribonucleotidesIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019

Therapy/Procedure

38	Therapeutics 01/2022 - 08/2002
10	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
3	Radiotherapy 11/2020 - 01/2019
3	Lasers (Laser) 09/2005 - 01/2002
1	Palliative Care (Palliative Therapy) 01/2021
1	Cytoreduction Surgical Procedures 01/2019